Evaluation of the clinical effectiveness of Safetac soft silicone dressings in the management of skin tears
Evaluation of the effect of safetac soft silicone dressings on healing rates of skin tears, and impact on peri-wound skin
Nursing Education & Research, Southern Health
400 participants
May 1, 2006
Interventional
Conditions
Summary
To objectively evaluate the efficacy of Safetac soft silicone dressings compared with standard treatment, on skin tear healing rates. Also to measure the impact of wound dressings on the surrounding skin. It is expected that a significantly greater proportion of patient skin tears treated with soft silicone will be healed, without trauma to the surrounding skin, at 7 days when compared with the group receiving standard treatment
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A randomised prospective clinical trial. Safetac soft silicone coated dressings (Mepitel and Mepilex Border) after seven days of treatment.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000092594